[Clinical studies in therapy using coagulation-active plasma concentrates].
D000933:Antifibrinolytic Agents; D001778:Blood Coagulation Disorders / Q000628:therapy*; D001779:Blood Coagulation Factors; D001792:Blood Platelets; D001793:Blood Preservation; D001803:Blood Transfusion; D002951:Citrates / Q000009:adverse effects; D004573:Electrolytes / Q000378:metabolism; D005112:Extracorporeal Circulation / Q000009:adverse effects; D005167:Factor VII / Q000627:therapeutic use; D006461:Hemolysis; D006467:Hemophilia A / Q000628:therapy; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000097:blood; D006801:Humans; D010952:Plasma Substitutes; D013916:Thrombelastography; D065227:Transfusion Reaction
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D002951:Citrates; D004573:Electrolytes; D010952:Plasma Substitutes; D005167:Factor VII; D006493:Heparin
Klinische Erfahrungen bei der Therapie mit gerinnungsaktiven Plasmakonzentraten.